acquired
Stage
1
Investors
About
Arkis BioSciences is a medical device company developing surgical tools and implantable devices aimed at improving neurosurgical treatment of intracranial hypertension caused by conditions such as hydrocephalus, traumatic brain injury, and hemorrhagic stroke.
Explore Arkis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.